FDA Approves ImClone, BMS' Erbitux

Drug Industry Daily
KEYWORDS FDA / Rx
A A

The FDA has approved ImClone Systems’ colon cancer drug Erbitux as a treatment for head and neck cancer.

To View This Article:

Login

Subscribe To Drug Industry Daily